Citadel Advisors’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.56M | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $187 | Sell |
|
|||||
|
2024
Q4 | $19.1K | Sell |
|
|||||
|
2024
Q3 | $155K | Sell |
|
|||||
|
2024
Q2 | $4.05M | Buy |
|
|||||
|
2024
Q1 | $323K | Sell |
|
|||||
|
2023
Q4 | $1.2M | Buy |
|
|||||
|
2023
Q3 | $2.08K | Sell |
|
|||||
|
2023
Q2 | $944K | Buy |
|
|||||
|
2023
Q1 | $269K | Sell |
|
|||||
|
2022
Q4 | $310K | Buy |
|
|||||
|
2022
Q3 | $306K | Sell |
|
|||||
|
2022
Q2 | $308K | Sell |
|
|||||
|
2022
Q1 | $945K | Buy |
|
|||||
|
2021
Q4 | $130K | Sell |
|
|||||
|
2021
Q3 | $225K | Buy |
|
|||||
|
2021
Q2 | $54K | Sell |
|
|||||
|
2021
Q1 | $778K | Buy |
|
|||||
|
2020
Q4 | – | Hold |
|
|||||
|
2020
Q3 | – | Hold |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $143K | Sell |
|
|||||
|
2019
Q4 | $1.32M | Buy |
|
|||||
|
2019
Q3 | $617K | Sell |
|
|||||
|
2019
Q2 | $3.41M | Buy |
|
|||||
|
2019
Q1 | $1.73M | Sell |
|
|||||
|
2018
Q4 | $2.23M | Buy |
|
|||||
|
2018
Q3 | $146K | Sell |
|
|||||
|
2018
Q2 | $1.25M | Sell |
|
|||||
|
2018
Q1 | $1.01M | Sell |
|
|||||
|
2017
Q4 | $1.67M | Buy |
|
|||||
|
2017
Q3 | $788K | Sell |
|
|||||
|
2017
Q2 | $1.82M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $257K | Buy |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $711K | Buy |
|
|||||
|
2015
Q4 | $199K | Buy |
|
|||||
|
2015
Q3 | $44K | Sell |
|
|||||
|
2015
Q2 | $283K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $41K | Sell |
|
|||||
|
2014
Q3 | $199K | Buy |
|
|||||
|
2014
Q2 | $184K | Buy |
|
|||||
|
2014
Q1 | $173K | Buy |
|
|||||
|
2013
Q4 | $104K | Buy |
|
|||||
|
2013
Q3 | $115K | Sell |
|
|||||
|
2013
Q2 | $1.04M | Buy |
|